Tesa/Ipa Blend

A peptide combination studied for its synergistic effects on growth hormone secretion, metabolic health, and recovery, offering a balanced approach to GH regulation.

The Tesamorelin/Ipamorelin Blend is a combination of two peptides, each with distinct mechanisms of action targeting growth hormone (GH) regulation. Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, stimulates the pituitary gland to increase endogenous GH secretion, leading to elevated levels of insulin-like growth factor-1 (IGF-1). It is primarily studied for its effects on reducing visceral fat and improving metabolic markers. Ipamorelin, a selective growth hormone secretagogue, binds to the ghrelin receptor (GHS-R1a) to enhance the natural pulsatile release of GH.

Unlike some other secretagogues, Ipamorelin minimizes off-target effects, such as elevations in cortisol or prolactin. When combined, these peptides work synergistically to optimize GH secretion patterns, offering potential benefits in studies focused on body composition, recovery, and aging. Researchers are exploring this blend for its potential to enhance anabolic processes while maintaining a balanced hormonal profile.